Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
TomoTherapy Incorporated
University Clinic Heidelberg Explores Advanced TomoTherapy® Delivery Technique
March 3rd, 2009
TomoTherapy Incorporated (NASDAQ: TOMO) announced that research partner University Clinic Heidelberg, Germany, has demonstrated the ability to dramatically reduce treatment times for the TomoTherapy® Hi·Art® system, while at the same time improving plan quality by further reducing radiation dose to normal tissue. Based on an in-depth planning study, University Clinic Heidelberg researchers anticipate that a reduction in treatment time of between 40 to 75 percent will be possible with next-generation delivery techniques currently in development by TomoTherapy. Detailed findings of the study will be published later this year. University Clinic Heidelberg, one of the top...
Source: Cancer Weekly (2009-03-03)
|
